Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
-
+
PL01 - Opening Plenary 1: Immunotherapy & Vaccines (Live Streamed Session)
- Type: Plenary
- Track: N/A
- Presentations: 20
- Coordinates: 8/06/2022, 18:15 - 19:45, Hall C1
-
+
PL01.01 - Welcome and Introduction
Author(s): Silvia Novello- Abstract
Loading... -
+
Session Moderator
Author(s): Silvia Novello- Abstract
Loading...
-
+
EP05.01 - Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Type: E-Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Chemoradiotherapy and Radiotherapy
- Presentations: 34
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP05.01-024 - Real-life Management of Stage III NSCLC Patients in Italy: The BE-PACIFIC Observational Study
Author(s): Silvia Novello- Abstract
Loading...
-
+
EP06.01 - Management of Lung Cancer in the Era of COVID-19
- Type: E-Poster
- Track: Management of Lung Cancer in the Era of COVID-19
- Presentations: 17
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP06.01-006 - Multidisciplinary Team during the COVID-19 Pandemic: The BE-PACIFIC Italian Observational Study Analysis.
Author(s): SARA RAMELLA- Abstract
Loading...
-
+
EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Type: E-Poster
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Presentations: 171
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP08.02-101 - Real-world Data from KRAS-mutant Advanced NSCLC: the ATLAS Multicenter Cohort Study
Author(s): Maristella Bungaro- Abstract
Loading... -
+
EP08.02-140 - MET Biomarker-based Preliminary Efficacy Analysis in SAVANNAH: savolitinib+osimertinib in EGFRm NSCLC Post-Osimertinib
Author(s): Myung-Ju Ahn- Abstract
Loading...
-
+
EP10.01 - Palliative and Supportive Care
- Type: E-Poster
- Track: Palliative and Supportive Care
- Presentations: 20
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP10.01-015 - The Role of CT-Scan as a Body Composition Tool in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients.
Author(s): Anna Maria Morelli- Abstract
Loading...
-
+
EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Type: E-Poster
- Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
- Presentations: 46
- Coordinates: 8/07/2022, 09:45 - 18:00, Exhibit Hall - Hall B
-
+
EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity
Author(s): Francesco Passiglia- Abstract
Loading... -
+
EP16.03-040 - Biomarkersatlas.com: the Italian NSCLC Precision Medicine Knowledge Data Base
Author(s): Umberto Malapelle- Abstract
Loading...
-
+
P1.11 - Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- Type: Regular Poster
- Track: Locally Advanced Non-small Cell Lung Cancer - Neoadjuvant and Adjuvant Therapy
- Presentations: 2
- Coordinates: 8/07/2022, 17:00 - 19:00, Exhibit Hall - Hall B
-
+
P1.11-01 - Cobolimab With Dostarlimab and Docetaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
Author(s): Hye Ryun Kim- Abstract
Loading...
-
+
OA15 - Patient Selection in Advanced NSCLC Immunotherapy
- Type: Oral
- Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
- Presentations: 10
- Moderators:Pilar Garrido
- Coordinates: 8/09/2022, 14:30 - 15:30, Hall C7
-
+
OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
15:02 - 15:12 | Author(s): Delvys Rodriguez-Abreu
- Abstract
Loading...
